| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/02/2013 | CN101948859B shRNA expression vector expressed by specificity inhibitor SET protein, construction method and application thereof |
| 01/02/2013 | CN101942475B Micro-loop free expression vector and construction method and application thereof |
| 01/02/2013 | CN101824090B Monoclonal antibody hpam4 |
| 01/02/2013 | CN101735981B Process for producing cytotoxic lymphocyte |
| 01/02/2013 | CN101663399B An anti-hcv vaccine and preparation methods and uses thereof |
| 01/02/2013 | CN101443048B Dendritic polymers with enhanced amplification and interior functionality |
| 01/02/2013 | CN101148661B Human papilloma virus 16 type coat protein virus-like particles, preparation method and use thereof |
| 01/01/2013 | US8344131 Organic compositions to treat beta-ENaC-related diseases |
| 01/01/2013 | US8344130 Organic compositions to treat Beta-ENaC-related diseases |
| 01/01/2013 | US8344129 Organic compositions to treat Beta-ENaC-related diseases |
| 01/01/2013 | US8344127 Organic compositions to treat beta-ENaC-related diseases |
| 01/01/2013 | US8344125 Modified iRNA agents |
| 01/01/2013 | US8344121 Nanoprobes for detection or modification of molecules |
| 01/01/2013 | US8344116 Polymers and complexes for delivery of nucleic acids to intracellular targets |
| 01/01/2013 | US8343941 Compositions and methods for gene silencing |
| 01/01/2013 | US8343939 Methods of modulating angiogenesis |
| 01/01/2013 | US8343938 Uses and compositions comprising miRNAs |
| 01/01/2013 | US8343761 Methods of generating and using antibody-producing cells |
| 01/01/2013 | US8343494 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 01/01/2013 | US8343487 Large-scale production of soluble hyaluronidase |
| 12/27/2012 | WO2012178033A2 Serpina1 sirnas: compositions of matter and methods of treatment |
| 12/27/2012 | WO2012178022A2 Therapeutic applications targeting sarm1 |
| 12/27/2012 | WO2012177949A2 Compositions and methods for inhibition of expression of protein c (proc) genes |
| 12/27/2012 | WO2012177947A2 Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes |
| 12/27/2012 | WO2012177921A2 Compositions and methods for inhibiting hepcidin antimicrobial peptide (hamp) or hamp-related gene expression |
| 12/27/2012 | WO2012177903A2 Methods of treating cognitive impairment |
| 12/27/2012 | WO2012177856A2 Cognition modification |
| 12/27/2012 | WO2012177784A2 Angiopoietin-like 3 (angptl3) irna compostions and methods of use thereof |
| 12/27/2012 | WO2012177481A2 Fibroblast growth factor receptor inhibition for the treatment of disease |
| 12/27/2012 | WO2012176853A1 Protein comprising truncated form of extracellular domain protein of frizzled 2, and pharmaceutical composition for treating bone diseases which comprises said protein |
| 12/27/2012 | WO2012176282A1 Apoptosis-inducing agent |
| 12/27/2012 | WO2012175052A1 Sensitizer for reversing or reducing radiotherapy resistance in cases of esophageal carcinoma, screening method and use thereof |
| 12/27/2012 | WO2012174970A1 Use of pigr as molecular marker in early recurrence and/or metastasis of tumours and intervention target for anti-metastatic drugs |
| 12/27/2012 | WO2012145597A3 Recombinant virus products and methods for inhibition of expression of myotilin |
| 12/27/2012 | WO2012142434A8 Aav mediated ctla-4 gene transfer to treat sjogren's syndrome |
| 12/27/2012 | WO2012135081A3 Lin28-mediated control of let-7 biogenesis |
| 12/27/2012 | WO2012129335A3 Hyd1 peptides for relapsed cancer |
| 12/27/2012 | WO2012122015A3 Selective inhibitors of tumor-initiating cells |
| 12/27/2012 | WO2012107908A3 Nts-polyplex nanoparticles system for gene therapy of cancer |
| 12/27/2012 | WO2012079046A3 Compositions and methods for inhibiting expression of klf-1 and bcl11a genes |
| 12/27/2012 | US20120331574 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 12/27/2012 | US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 12/27/2012 | US20120329856 Methods And Compositions For Reducing Viral Genome Amounts In A Target Cell |
| 12/27/2012 | US20120329727 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2 |
| 12/27/2012 | US20120329710 Methods of Inducing Regulated Pancreatic Hormone Production in Non-Pancreatic Islet Tissues |
| 12/27/2012 | US20120329063 Novel means for the diagnosis and therapy of ctcl |
| 12/27/2012 | US20120329052 Identification of a dna variant associated with adult type hypolactasia |
| 12/27/2012 | US20120328699 Method and composition for treatment of skeletal dysplasias |
| 12/27/2012 | US20120328693 Method for enhancing immune response in the treatment of infectious and malignant diseases |
| 12/27/2012 | US20120328651 Chimpanzee adenovirus vaccine carriers |
| 12/27/2012 | US20120328650 Modified vaccinia ankara virus variant |
| 12/27/2012 | US20120328609 Modulation of Axon Degeneration |
| 12/27/2012 | US20120328590 Anti-cancer therapeutic strategy to overcome cancer resistance and to enable tailoring treatment to patients |
| 12/27/2012 | US20120328584 Biological Pacemaker |
| 12/27/2012 | US20120328575 Modified Oncolytic Viruses |
| 12/27/2012 | US20120328559 Compositions and Methods for Treating Inflammatory Lung Disease |
| 12/27/2012 | US20120328520 Conjugate with target-finding ligand and use thereof |
| 12/27/2012 | CA2841203A1 Apoptosis-inducing agent |
| 12/26/2012 | EP2536741A2 Gene fusion targeted therapy |
| 12/26/2012 | EP2536436A1 Antimir-451 for the treatment of polycythemias |
| 12/26/2012 | EP2536435A1 Monkey homolog of human interferon omega |
| 12/26/2012 | CN102844435A Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
| 12/26/2012 | CN102841200A Use of pIgR as molecular marker of early recurrence and/or metastasis of tumor and intervening target spot of anti-tumor metastasizing medicine |
| 12/26/2012 | CN102839194A Recombinant adeno-associated virus vector, and preparation method and application thereof |
| 12/26/2012 | CN102839192A miRNA (micro Ribonucleic Acid) absorption carrier, preparation method and uses thereof |
| 12/26/2012 | CN102839187A miR-29 absorption sequence, absorption carrier and uses thereof |
| 12/26/2012 | CN102839186A Preparation and application of recombinant Mycobacterium smegmatis expressing NY-ESO-1 |
| 12/26/2012 | CN102838657A Human tumor marker TBRG4 (transforming growth factor beta regulator 4) polypeptide and application thereof |
| 12/26/2012 | CN102836442A Application of DCX-SPRAC double-gene co-expression vector in preparation of radiotherapy sensitization agent |
| 12/26/2012 | CN102836441A Method for enhancing immune response in treatment of infectious and malignant disease |
| 12/26/2012 | CN102836440A Polypeptide-modified brain-targeted nanometer gene delivery system and preparation method thereof |
| 12/26/2012 | CN102836439A Application of small interfering ribonucleic acid (siRNA) as substance for restraining formation of colloidal scar after central nervous system injury |
| 12/26/2012 | CN102836438A Multi-component biological transport systems |
| 12/26/2012 | CN102836420A Methods and compositions involving MDA-7 |
| 12/26/2012 | CN102382836B siRNAs (small interfering ribonucleic acids) for suppressing expression of PAR-1 (proteinase activated receptor-1) genes and application thereof |
| 12/26/2012 | CN102382834B SiRNA for inhibiting expression of PAR-1 gene and application thereof |
| 12/26/2012 | CN102327623B Preparation method of DNA (deoxyribonucleic acid) vaccine nanoparticles containing PLGA (Poly-lactide-co-glycolide) for ND (necastle disease) |
| 12/26/2012 | CN102168088B T cell immunogen gene TI and applications thereof in foot-and-mouth disease protein subunit vaccine and inactivated vaccine |
| 12/25/2012 | US8338385 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 12/25/2012 | US8338384 Method for treating ocular neovascularization |
| 12/25/2012 | US8338168 Chimeric glycoproteins and pseudotyped lentiviral vectors |
| 12/25/2012 | US8338150 Method for combined parallel agent delivery and electroporation for cell structures an use thereof |
| 12/25/2012 | US8338091 Methods and compositions for seamless cloning of nucleic acid molecules |
| 12/25/2012 | US8337868 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
| 12/25/2012 | US8337861 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 12/25/2012 | US8337860 Development of dengue virus vaccine components |
| 12/25/2012 | US8337859 Vectors for multiple gene expression |
| 12/25/2012 | US8337817 Preparation for transnasal application |
| 12/20/2012 | WO2012174555A2 Composition and method for stabilization and delivery of therapeutic molecules |
| 12/20/2012 | WO2012174549A2 Blockade of eosinophil production by toll-like receptors |
| 12/20/2012 | WO2012174543A2 Phosphonium-containing polyelectrolytes for nonviral gene delivery |
| 12/20/2012 | WO2012174365A2 Methods for producing pancreatic precursor cells and uses thereof |
| 12/20/2012 | WO2012174280A2 Methods and compositions for modulating myofibroblast activities |
| 12/20/2012 | WO2012174224A2 Methods for administering nucleic acid-based therapeutics |
| 12/20/2012 | WO2012173984A2 Gβγ BINDING SITE ON THE PIK3CB GENE PRODUCT AND METHODS OF USE |
| 12/20/2012 | WO2012172012A1 New treatment for muscular dystrophies |
| 12/20/2012 | WO2012145601A3 Adeno-associated virus virions with variant capsid and methods of use thereof |
| 12/20/2012 | WO2012115437A3 Pharmaceutical composition for cancer treatment or metastasis inhibition containing expression or activation inhibitors of map7d2 protein, novel cancer therapeutic target |
| 12/20/2012 | WO2012102527A3 Novel use of regulatory t cell-specific surface protein lrig-1 |
| 12/20/2012 | WO2009013324A9 Vector particles for targeting cd34+ cells |